LOS ANGELES, March 2, 2017 /PRNewswire/ --áCatasys, Inc. (OTCQB: CATS), a provider of proprietary predictive analytics andintegrated treatment solutions to health plans, announced today that Terren Peizer, Chairman of the Board and Chief Executive Officer, will present at the 29th Annual ROTH Conference to be held at The Ritz-Carlton,
Investors attending the conference who wish to meet with Mr. Peizer for a one-on-one meeting should notify their appropriate contact.
For more information and registration, please visit the conference website.
About Catasys, Inc.
Catasys, Inc. provides big data based analytics and predictive modeling driven behavioral healthcare services to health plans and their members through its OnTrak solution. Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to improve member health and, at the same time, lower costs to the insurer for underserved populations where behavioral health conditions cause or exacerbate co-existing medical conditions. The solution utilizes proprietary analytics and proprietary enrollment, engagement and behavioral modification capabilities to assist members who otherwise do not seek care through a patient-centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient treatment solution.
OnTrak is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is currently available to members of several leading health plans in Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. For further information, please visit catasys.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/catasys-to-participate-in-the-29th-annual-roth-conference-on-march-15-2017-300416329.html
SOURCE Catasys, Inc.
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All